Naoko Imura

Title: Naoko Imura: Innovator in Pharmaceutical Compounds

Introduction

Naoko Imura is a prominent inventor based in Osaka, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that interact with specific receptors in the body. Her work is characterized by a focus on innovative drug substances that have the potential to improve therapeutic outcomes.

Latest Patents

Naoko Imura holds a patent for a compound known as "Salt and crystal form of compound having agonistic activity to S1P5 receptor." This compound, referred to as Compound I, exhibits high S1P receptor-selective agonist activity. The patent also covers the crystal forms of Compound I, the salts of Compound I, and the crystal forms of salts thereof, which are provided as drug substances for pharmaceuticals.

Career Highlights

Imura is associated with Ono Pharmaceutical Co., Ltd., a leading company in the pharmaceutical industry. Her work at Ono has allowed her to focus on the development of innovative therapeutic agents. With her expertise, she has contributed to advancing the understanding of receptor interactions and their implications for drug development.

Collaborations

Naoko Imura has collaborated with notable colleagues, including Shuhei Otani and Takayuki Fujito. These collaborations have fostered a productive environment for research and innovation, leading to advancements in pharmaceutical compounds.

Conclusion

Naoko Imura's contributions to the field of pharmaceuticals highlight her role as an innovator in drug development. Her patent for Compound I demonstrates her commitment to advancing medical science and improving patient care.